Compare CIM & AORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CIM | AORT |
|---|---|---|
| Founded | 2007 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medical/Dental Instruments |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.4B |
| IPO Year | 2007 | 1996 |
| Metric | CIM | AORT |
|---|---|---|
| Price | $10.17 | $22.57 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 5 |
| Target Price | $15.25 | ★ $49.40 |
| AVG Volume (30 Days) | ★ 1.1M | 529.0K |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | ★ 10.92% | N/A |
| EPS Growth | 56.36 | ★ 165.62 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $298,836,000.00 |
| Revenue This Year | $1.62 | $14.20 |
| Revenue Next Year | $2.48 | $11.20 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 18.01 |
| 52 Week Low | $10.05 | $19.16 |
| 52 Week High | $14.18 | $48.25 |
| Indicator | CIM | AORT |
|---|---|---|
| Relative Strength Index (RSI) | 22.70 | 32.16 |
| Support Level | N/A | $21.76 |
| Resistance Level | $13.82 | $25.04 |
| Average True Range (ATR) | 0.24 | 0.93 |
| MACD | -0.07 | -0.18 |
| Stochastic Oscillator | 7.34 | 4.65 |
Chimera Investment Corporation is an internally managed REIT whose principal business objective is to provide attractive risk-adjusted returns and distributable income through investment performance linked to mortgage credit fundamentals. Through its mortgage lending, investment management, and advisory services platforms, the Company operates as a fully integrated mortgage business that originates, manages, and invests in a diversified range of mortgage assets. The Company invests, directly or indirectly, generally on a levered basis across a spectrum of mortgage assets, including residential mortgage loans, Non-Agency RMBS, Agency RMBS, Agency CMBS, MSRs, business purpose and investor loans, including RTLs, and other real estate-related assets.
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.